Kura Oncology

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$1,270
Gross Profit
-202
-234
1,056
EBITDA
-53,784
-50,229
-48,893
-42,178
EBIT
-53,992
-50,431
-49,127
-42,392
Net Income
-54,404
-50,837
-49,525
-42,786
Net Change In Cash
0
0
0
1,270
Free Cash Flow
-43,440
-42,546
-48,928
-34,324
Cash
49,480
45,183
41,506
37,318
Basic Shares
86,950
86,635
83,905
77,337

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-849
-759
-558
-194
EBITDA
-164,955
-139,106
-129,706
-91,705
EBIT
-165,804
-139,865
-130,264
-91,899
Net Income
-152,631
-136,069
-129,908
-89,431
Net Change In Cash
0
0
0
0
Cost of Revenue
-38,870
-234,821
299,568
Free Cash Flow
-124,992
-110,688
-105,698
-72,001
Cash
37,318
51,802
90,672
325,493
Basic Shares
73,229
66,989
66,352
53,077

Earnings Calls

Quarter EPS
2024-09-30
-$0.63
2024-06-30
-$0.59
2024-03-31
-$0.59
2023-12-31
-$0.55